“The purpose of this report is to cover the definition, description, and forecast of the North American mannequin-based simulation market. It involves deep-dive analysis of market segmentation which comprises of type, end-user, and geography. The report also gives the deep insight of strategic analysis of key players for the market. The North American mannequin-based simulation market by type is segmented into patient simulators, task trainer, ultrasound simulators, surgical simulators, endovascular simulators, dental simulators, and eye simulators. On the basis of end-user, the market is segmented into military organizations, academic institutes, and hospitals.
The market in the U.S. accounted for the largest share in the North American mannequin-based simulation market and is expected to grow at a CAGR of 19.3% from 2014 to 2019. The large share is attributed to rising adoption of simulation technologies, increasing demand for minimally invasive treatment, and increasing focus on patient safety. This will improve the demand for mannequin-based simulation in these markets. However, limited availability of funds is hindering the growth of this market.
The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies in this market are also detailed.
The main companies operating in this market in globally are CAE, Inc. (U.S.), Laerdal Medical AS (Norway), Gaumard Scientific Company Inc. (U.S.), Limbs & Things Ltd. (U.K.), and others.
”
“TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 SEGMENTATION & COVERAGE 12
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 INTEGRATED ECOSYSTEM OF MANNEQUIN-BASED SIMULATION MARKET 13
2.2 ARRIVING AT THE MANNEQUIN-BASED SIMULATION MARKET SIZE 14
2.2.1 TOP-DOWN APPROACH 14
2.2.2 BOTTOM-UP APPROACH 15
2.2.3 MACROINDICATOR-BASED APPROACH 16
2.3 ASSUMPTIONS 17
3 EXECUTIVE SUMMARY 18
4 MARKET OVERVIEW 19
4.1 INTRODUCTION 19
4.2 MANNEQUIN-BASED SIMULATION MARKET: COMPARISON WITH PARENT MARKET 20
4.3 MARKET DRIVERS AND INHIBITORS 21
4.4 KEY MARKET DYNAMICS 22
5 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 24
5.1 INTRODUCTION 25
5.2 NORTH AMERICA: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE (COMPARISON WITH PARENT MARKET) 26
5.3 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY GEOGRAPHY 27
5.4 NORTH AMERICA: TASK TRAINERS MARKET, BY GEOGRAPHY 28
5.5 NORTH AMERICA: SURGICAL SIMULATORS MARKET, BY GEOGRAPHY 29
5.6 NORTH AMERICA: ENDOVASCULAR SIMULATORS MARKET, BY GEOGRAPHY 30
5.7 NORTH AMERICA: ULTRASOUND SIMULATORS MARKET, BY GEOGRAPHY 31
5.8 NORTH AMERICA: DENTAL SIMULATORS MARKET, BY GEOGRAPHY 32
5.9 NORTH AMERICA: EYE SIMULATORS MARKET, BY GEOGRAPHY, 2013 – 2019 (USD MN) 33
6 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET, BY END- USER 35
6.1 INTRODUCTION 36
6.2 NORTH AMERICA: ACADEMIC INSTITUTES MARKET, BY GEOGRAPHY 37
6.3 NORTH AMERICA: HOSPITALS MARKET, BY GEOGRAPHY 38
6.4 NORTH AMERICA: MILITARY ORGANIZATIONS MARKET, BY GEOGRAPHY 39
7 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET, BY GEOGRAPHY 40
7.1 INTRODUCTION 41
7.2 U.S.: MANNEQUIN-BASED SIMULATION MARKET 42
7.2.1 U.S.: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 42
7.2.2 U.S.: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 43
7.3 CANADA: MANNEQUIN-BASED SIMULATION MARKET 44
7.3.1 CANADA: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 45
7.3.2 CANADA: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 46
7.4 MEXICO: MANNEQUIN-BASED SIMULATION MARKET 47
7.4.1 MEXICO: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 47
7.4.2 MEXICO: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 48
8 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET: COMPETITIVE LANDSCAPE 50
8.1 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET: COMPANY SHARE ANALYSIS 50
8.2 MERGERS & ACQUISITIONS 51
8.3 NEW PRODUCT LAUNCH 51
9 NORTH AMERICA MANNEQUIN-BASED SIMULATION MARKET, BY COMPANY 53
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 CAE, INC. 53
9.2 LAEDERAL MEDICAL AS 58
9.3 GAUMARD SCIENTIFIC COMPANY, INC. 65
9.4 KYOTO KAGAKU CO., LTD. 71
9.5 LIMBS & THINGS, LTD. 74
9.6 MENTICE AB 82
9.7 MOOG, INC. 85
9.8 SIMULAB CORPORATION 87
9.9 SIMULAIDS, INC 96
9.10 SURGICAL SCIENCE SWEDEN AB 103
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 106
10.1 CUSTOMIZATION OPTIONS 106
10.1.1 LOW-COST SOURCING LOCATIONS 106
10.1.2 REGULATORY FRAMEWORK 106
10.1.3 IMPACT ANALYSIS 106
10.2 RELATED REPORTS 107
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 108
10.3.1 RT SNAPSHOTS 109
“
